The bill requires the United States Postal Service to continue selling the Alzheimer's semipostal stamp for six additional years beyond when it would normally stop being offered. A semipostal stamp is a special postage stamp sold at a premium price, with the extra revenue dedicated to a charitable cause. In this case, all proceeds from stamp sales above the standard postage rate go to the National Institutes of Health to fund Alzheimer's disease research, with payments made at least twice per year. The stamp has been available since November 2017, and this legislation extends its availability to allow the public an ongoing way to contribute to Alzheimer's research through their regular mail purchases. The bill affects postal customers who wish to support this cause and benefits Alzheimer's research funding through the National Institutes of Health.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.